Paricalcitol oral como agente antiproteinúrico en la enfermedad renal crónica

Statistics

Oral paricalcitol as antiproteinuric agent in chronic kidney disease

Alberto de Lorenzoa, Alberto de Lorenzob, Laura Salanovaa, Laura Salanovab, Andrew S. Bombackc, Andrew S. Bombackd, María Moyaa, Maria Moyab, Francisco Coronele, Carmen Bernisa, Carmen Bernisb, José A. Sánchez-Tomeroa, José Antonio Sánchez-Tomerob, Vicente Álvareza, Vicente Álvarezb

a Servicio de Nefrología, Hospital Universitario de La Princesa, Madrid, Spain,

b Servicio de Nefrología, Hospital Universitario de La Princesa, Madrid, Madrid, España,

c Division of Nephrology, Columbia University College of Physicians and Surgeons, Presbyterian Hospital, New York, USA,

d Division of Nephrology, Columbia University College of Physicians and Surgeons, Presbyterian Hospital, New York, New York, USA,

e Servicio de Nefrología, Hospital Clinico Universitario San Carlos, Madrid, Madrid, España,

Read

13648

Times
was read the article

3553

Total PDF

10095

Total HTML

Share statistics

Article information

ISSN: 02116995
Original language: Spanish

DOI:10.3265/Nefrologia.pre2013.Jun.11928

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	21	51	72
2025 5	106	71	177
2025 4	80	31	111
2025 3	106	56	162
2025 2	87	46	133
2025 1	67	60	127
2024 12	74	35	109
2024 11	63	59	122
2024 10	61	46	107
2024 9	54	34	88
2024 8	77	72	149
2024 7	60	43	103
2024 6	70	51	121
2024 5	66	34	100
2024 4	65	57	122
2024 3	55	31	86
2024 2	32	36	68
2024 1	29	30	59
2023 12	37	28	65
2023 11	46	31	77
2023 10	47	40	87
2023 9	57	36	93
2023 8	38	21	59
2023 7	64	34	98
2023 6	66	17	83
2023 5	60	33	93
2023 4	46	28	74
2023 3	63	25	88
2023 2	22	30	52
2023 1	42	45	87
2022 12	71	40	111
2022 11	43	37	80
2022 10	69	60	129
2022 9	47	44	91
2022 8	52	63	115
2022 7	51	82	133
2022 6	32	57	89
2022 5	41	43	84
2022 4	44	50	94
2022 3	31	66	97
2022 2	39	85	124
2022 1	51	39	90
2021 12	30	59	89
2021 11	42	47	89
2021 10	37	55	92
2021 9	41	72	113
2021 8	51	76	127
2021 7	33	92	125
2021 6	32	27	59
2021 5	38	43	81
2021 4	94	53	147
2021 3	64	34	98
2021 2	47	21	68
2021 1	34	19	53
2020 12	47	21	68
2020 11	34	31	65
2020 10	33	13	46
2020 9	27	13	40
2020 8	38	9	47
2020 7	35	11	46
2020 6	29	23	52
2020 5	50	29	79
2020 4	47	20	67
2020 3	23	20	43
2020 2	50	28	78
2020 1	41	20	61
2019 12	44	40	84
2019 11	47	21	68
2019 10	29	25	54
2019 9	27	27	54
2019 8	29	22	51
2019 7	34	27	61
2019 6	14	17	31
2019 5	26	25	51
2019 4	57	44	101
2019 3	45	33	78
2019 2	31	40	71
2019 1	33	36	69
2018 12	96	56	152
2018 11	144	24	168
2018 10	119	30	149
2018 9	60	15	75
2018 8	55	20	75
2018 7	42	18	60
2018 6	53	23	76
2018 5	42	10	52
2018 4	59	14	73
2018 3	48	9	57
2018 2	33	10	43
2018 1	45	10	55
2017 12	52	12	64
2017 11	48	10	58
2017 10	40	10	50
2017 9	25	10	35
2017 8	41	18	59
2017 7	45	10	55
2017 6	45	22	67
2017 5	48	14	62
2017 4	52	18	70
2017 3	37	18	55
2017 2	26	18	44
2017 1	15	15	30
2016 12	115	14	129
2016 11	121	10	131
2016 10	118	17	135
2016 9	204	11	215
2016 8	286	15	301
2016 7	248	2	250
2016 6	158	0	158
2016 5	177	0	177
2016 4	145	0	145
2016 3	132	0	132
2016 2	152	0	152
2016 1	186	0	186
2015 12	160	0	160
2015 11	139	0	139
2015 10	129	0	129
2015 9	87	0	87
2015 8	122	0	122
2015 7	123	0	123
2015 6	80	0	80
2015 5	160	0	160
2015 4	40	0	40
2015 2	1998	0	1998

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter